{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_tocilizumab",
          "name": "Tocilizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_loperamide",
          "name": "Loperamide"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_probiotics",
          "name": "Probiotics"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tocilizumab",
          "type": "Drug",
          "label": "Tocilizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclosporine",
          "type": "Drug",
          "label": "Cyclosporine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_loperamide",
          "type": "Drug",
          "label": "Loperamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_probiotics",
          "type": "Drug",
          "label": "Probiotics",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_Gastrointestinal_epithelial_barrier_disorders",
          "type": "Disease",
          "label": "Gastrointestinal epithelial barrier disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_cytokine_receptor",
          "type": "Target",
          "label": "Cytokine Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_inflammatory_marker",
          "type": "Target",
          "label": "Inflammatory Marker",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_barrier_function",
          "type": "Pathway",
          "label": "Epithelial Barrier Function Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_immune_modulation",
          "type": "Pathway",
          "label": "Immune Modulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_mesalamine",
          "target": "t_inflammatory_marker",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "常用于减少肠道炎症"
        },
        {
          "source": "drug_infliximab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "对 TNF-α 抑制的有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "作用机制与 infliximab 类似"
        },
        {
          "source": "drug_budesonide",
          "target": "p_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "类固醇减少免疫反应"
        },
        {
          "source": "drug_prednisone",
          "target": "p_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "可减少肠道炎症并降低组织损伤"
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对 IL-12/23 的新机制"
        },
        {
          "source": "drug_tocilizumab",
          "target": "t_cytokine_receptor",
          "relation": "inhibits",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "作用于 IL-6，调节免疫反应"
        },
        {
          "source": "drug_methotrexate",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "通过影响免疫应答来改善症状"
        },
        {
          "source": "drug_azathioprine",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "免疫抑制药物，改善肠道健康"
        },
        {
          "source": "drug_cyclosporine",
          "target": "p_immune_modulation",
          "relation": "modulates",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "常作为免疫抑制治疗"
        },
        {
          "source": "drug_loperamide",
          "target": "p_barrier_function",
          "relation": "modulates",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "减轻腹泻，可改善屏障功能"
        },
        {
          "source": "drug_probiotics",
          "target": "p_barrier_function",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "通过调节肠道微生物促进肠道屏障"
        },
        {
          "source": "t_cytokine_receptor",
          "target": "p_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "细胞因子受体在炎症通路中起关键作用"
        },
        {
          "source": "t_inflammatory_marker",
          "target": "p_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "标记物与炎症活动相关"
        },
        {
          "source": "p_inflammatory_response",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "炎症过程直接影响肠道屏障功能"
        },
        {
          "source": "p_barrier_function",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "屏障功能损害导致临床表现"
        },
        {
          "source": "p_immune_modulation",
          "target": "d_Gastrointestinal_epithelial_barrier_disorders",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "免疫调节影响肠道健康"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "通过不同药物干预途径，改善胃肠道上皮屏障功能并影响相关疾病",
        "confidence": "medium"
      },
      {
        "id": "C2",
        "text": "多种药物可通过调节免疫及炎症反应，支持肠道屏障维护",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物在适当剂量下能有效到达靶部位"
    ],
    "uncertainties": [
      "各药物的个体反应及其联合使用的安全性需进一步研究"
    ],
    "next_focus_for_pi": [
      "确认每种药物在特定疾病中的适应症及支持证据"
    ]
  }
}